Nov 7, 2024
 in 
Hot Stocks 🔥

‘Undervalued’ Pfizer Might Go Up 14.70% | Nemo

Name of opportunity: 👀

Pfizer Inc  

Is it undervalued?: 📈

Pfizer is currently priced 5.93% cheaper than it was a month ago, and analysts are saying that it might be ‘undervalued’. At its highest price in the last 5 years, it was worth $59.48 during Covid due to the success of its vaccine - but now, the price is nearly half that, at $27.48. 

How hot is this investment opportunity? 🔥🔥🔥

Check out Pfizer’s page in our investing app Nemo Money. Analysts predict the price of Pfizer Inc. might increase from $27.47 to $31.49 in the next 12 months. If you invested $1000, you might profit $147.02.

One reason why analysts think that Pfizer might increase in value is because of a new drug the company is developing. Danuglipron will be Pfizer’s contribution to the increasingly busy weight loss drug market - the difference is that it will be a daily pill rather than an injection like Novo Nordisk’s Wegovy or Eli Lilly’s Zepbound.

Analysts also consider Pfizer’s dividend yield to be ‘Above Average’. The yield of 5.59% offers a solid return for income investors. If you invested $1000 you would be paid $55.90 a year in dividends (based on the last 12 months).

Drug developer: 💊

Pfizer Inc. is a research-based biopharmaceutical company. The company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products around the world. This American multinational company is headquartered in New York, US. 

Which neme?: 🔍

7 Stocks With Dual Potential’, ‘Pharma’, and ‘Dividend Deadlines’ 

Download Nemo Money to check out Pfizer - if you’re a new user, you can access our registration bonus. We’ll give you 50% of the first $50 you top up with (or 50% of any amount up to that). 

Han Tan

Han Tan is Chief Market Analyst at Nemo.money, bringing over a decade of experience in financial markets as both a seasoned journalist and analyst. Known for his sharp insights into stocks, currencies, and commodities, Han has become a familiar face to national audiences through appearances on Bloomberg TV Malaysia, BFM 89.9, and NTV7 — earning him a trusted reputation in financial media. Before joining Nemo, Han served as Market Analyst at Exinity Group from 2019, where his commentary on macroeconomic trends and market-moving news was regularly featured by global outlets including Reuters, Bloomberg, CNN, BBC, and AFP. Today, Han brings that same clarity and depth to Nemo’s community, delivering content-led ideas that empower first-time investors to confidently navigate global markets.